137 related articles for article (PubMed ID: 8479178)
21. Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids.
Huong DT; Takahashi Y; Ide T
Nutrition; 2006 May; 22(5):546-52. PubMed ID: 16483743
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse.
Brix AE; Elgavish A; Nagy TR; Gower BA; Rhead WJ; Wood PA
Mol Genet Metab; 2002 Mar; 75(3):219-26. PubMed ID: 11914033
[TBL] [Abstract][Full Text] [Related]
23. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
[TBL] [Abstract][Full Text] [Related]
24. Vitamin A deficiency modifies lipid metabolism in rat liver.
Oliveros LB; Domeniconi MA; Vega VA; Gatica LV; Brigada AM; Gimenez MS
Br J Nutr; 2007 Feb; 97(2):263-72. PubMed ID: 17298694
[TBL] [Abstract][Full Text] [Related]
25. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.
Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G
Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373
[TBL] [Abstract][Full Text] [Related]
26. 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver.
Madsen L; Berge RK
Lipids; 1999 May; 34(5):447-56. PubMed ID: 10380116
[TBL] [Abstract][Full Text] [Related]
27. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I.
Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G
Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver.
Larosche I; Lettéron P; Fromenty B; Vadrot N; Abbey-Toby A; Feldmann G; Pessayre D; Mansouri A
J Pharmacol Exp Ther; 2007 May; 321(2):526-35. PubMed ID: 17277197
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
[TBL] [Abstract][Full Text] [Related]
30. Evidence for an impaired long-chain fatty acid oxidation and ketogenesis in Fao hepatoma cells.
Prip-Buus C; Bouthillier-Voisin AC; Kohl C; Demaugre F; Girard J; Pegorier JP
Eur J Biochem; 1992 Oct; 209(1):291-8. PubMed ID: 1356769
[TBL] [Abstract][Full Text] [Related]
31. Hormonal control of fatty acid oxidation during the neonatal period.
Pegorier JP; Prip-Buus C; Duee PH; Girard J
Diabete Metab; 1992; 18(1 Pt 2):156-60. PubMed ID: 1563551
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I gene transcription in cultured fetal rat hepatocytes.
Chatelain F; Kohl C; Esser V; McGarry JD; Girard J; Pegorier JP
Eur J Biochem; 1996 Feb; 235(3):789-98. PubMed ID: 8654430
[TBL] [Abstract][Full Text] [Related]
33. Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1.
Assimacopoulos-Jeannet F; Thumelin S; Roche E; Esser V; McGarry JD; Prentki M
J Biol Chem; 1997 Jan; 272(3):1659-64. PubMed ID: 8999842
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet.
Serviddio G; Giudetti AM; Bellanti F; Priore P; Rollo T; Tamborra R; Siculella L; Vendemiale G; Altomare E; Gnoni GV
PLoS One; 2011; 6(9):e24084. PubMed ID: 21909411
[TBL] [Abstract][Full Text] [Related]
35. Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors.
Vickers AE
Toxicol Pathol; 2009 Jan; 37(1):78-88. PubMed ID: 19234235
[TBL] [Abstract][Full Text] [Related]
36. [Heterogeneity of carnitine palmitoyltransferase deficiencies. Deficiency of CPT I in the hepatic form and CPT II in the muscular form].
Bonnefont JP; Ogier H; Mitchell G; Demaugre F; Pelet A; Saudubray JM; Frezal J
Arch Fr Pediatr; 1985; 42 Suppl 1():613-7. PubMed ID: 4083994
[TBL] [Abstract][Full Text] [Related]
37. Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity.
Mynatt RL; Park EA; Thorngate FE; Das HK; Cook GA
Biochem Biophys Res Commun; 1994 Jun; 201(2):932-7. PubMed ID: 8003033
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
Geneve J; Hayat-Bonan B; Labbe G; Degott C; Letteron P; Freneaux E; Dinh TL; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1987 Sep; 242(3):1133-7. PubMed ID: 3116197
[TBL] [Abstract][Full Text] [Related]
39. Hepatic β-oxidation and regulation of carnitine palmitoyltransferase (CPT) I in blunt snout bream Megalobrama amblycephala fed a high fat diet.
Lu KL; Xu WN; Wang LN; Zhang DD; Zhang CN; Liu WB
PLoS One; 2014; 9(3):e93135. PubMed ID: 24676148
[TBL] [Abstract][Full Text] [Related]
40. Aspects of the regulation of long-chain fatty acid oxidation in bovine liver.
Jesse BW; Emery RS; Thomas JW
J Dairy Sci; 1986 Sep; 69(9):2298-303. PubMed ID: 3782586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
